BSE filing, BSE: 543943. Summary written from the filing by ALFA Finder's alert engine.
Asarfi Hospital Ltd: key numbers
- Share price
- ₹166.95
- Market cap
- ₹328.5 Cr
- Revenue (annual)
- ₹173.5 Cr
- Net profit (annual)
- ₹16.66 Cr
- P/E (TTM)
- 19.7×Sector 34.1×
- Promoter holding
- 61.18%+0.01% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Asarfi Hospital Ltd
All →Asarfi Hospital Other Announcement
Asarfi Hospital Ltd has filed its shareholding pattern for the quarter ended September 30, 2026. This disclosure outlines the current distribution of equity shares.
Asarfi Hospital Credit Rating
Asarfi Hospital Ltd announced that CRISIL Ratings upgraded its bank facilities credit rating. The total rated bank facilities are now ₹60 Crore, enhanced from ₹46.5 Crore.
- Value
- ₹60.00 Cr
Asarfi Hospital Annual General Meeting
Asarfi Hospital Ltd's 21st Annual General Meeting held on September 18, 2026, saw shareholder approval for financial statements, director reappointment, and migration to the BSE Main Board.
Asarfi Hospital Annual Report
Asarfi Hospital Limited has submitted its Annual Report for the Financial Year 2025-26 in compliance with SEBI Listing Regulations.
Asarfi Hospital Other Announcement
Asarfi Hospital Limited has appointed M/s Ashutosh Kumar Sinha & Co as the Cost Auditor for the financial year 2026-27, as approved by the Board.
Asarfi Hospital Board Meeting Outcome
Asarfi Hospital approved its 21st AGM, appointment of auditors, and migration from BSE SME to the BSE Main Board and NSE.
Other board meeting date announcements
All →Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.
Parag Milk Foods Board Meeting Date
Parag Milk Foods has notified BSE of a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window closure runs from 1 October to 5 November 2026.
Vedant Fashions Board Meeting Date
Vedant Fashions will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half-year ended September 2026. The meeting is a prior intimation, so no results are approved yet.
Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.
EPL Board Meeting Date
EPL will hold a board meeting on November 4, 2026 to consider September quarter results. Trading window re-opens 48 hours after results are declared.